Update on completion of acquisition of stake in SN Genelab Private Limited

Dr. Lal PathLabs has completed the acquisition of a stake in SN Genelab Private Limited ("SN Gene").

Thu 1 Oct 2026

Transaction Completed

acquisition of a stake in SN Genelab Private Limited ("SN Gene") completed

Completion Date

October 01, 2026

Earlier Approval Intimation Date

September 24, 2026

Completion of stake acquisition in SN Genelab Private Limited

Dr. Lal PathLabs Limited has informed the stock exchanges that it has completed the acquisition of a stake in SN Genelab Private Limited, referred to as "SN Gene" in the update. This is an update to the company's earlier intimation dated September 24, 2026.

What the update says

• The Board of Directors of the Company had approved the acquisition of a stake in SN Genelab Private Limited. That approval was intimated earlier, on September 24, 2026.
• The Company has now completed the said acquisition on October 01, 2026.
• The completion was done as per the terms and conditions of the Agreement.
• The disclosures required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with the SEBI circular dated July 13, 2023, had already been duly intimated in the earlier intimation of September 24, 2026.

Why it matters

• Going from "approved" to "completed" tells the market that the transaction has moved past the approval stage. The earlier update was about a decision; this one confirms the decision has been acted upon.
• Buying a stake in another entity is a way for a company to add to its business footprint. Retail investors would typically read this as the company acting on a plan it had already announced.
• The word used in the update is "acquisition of stake". The update does not set out the size of the stake, the amount paid, or the identity of the seller, so the financial effect on Dr. Lal PathLabs cannot be judged from this document alone.

What to keep in mind

• This update carries no figures, so it does not by itself tell you how large the transaction is relative to the company's size.
• The company states that the disclosures linked to the earlier intimation were already made, and this letter is placed on record as an update.

Summary: The company has completed the acquisition of a stake in SN Genelab Private Limited on October 01, 2026, following the Board's earlier approval intimated on September 24, 2026, as per the terms and conditions of the Agreement.

Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.